(Q39587572)

13 September 2017

1 reference

title

The reproductive toxicity of ovulation induction (English)

1 reference

13 September 2017

Scialli AR

1

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 March 1986

1 reference

13 September 2017

published in

Fertility and Sterility

1 reference

13 September 2017

volume

45

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

315-323

1 reference

Clomiphene citrate: mechanism(s) and site(s) of action--a hypothesis revisited.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

A rational and practical approach to clomiphene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Induction of luteal phase defect with clomiphene citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Effect of clomiphene citrate on preovulatory rat follicles in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Antiestrogenic action of high-dose clomiphene in primates pituitary augmentation but with ovarian attenuation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Activity of a human follicular fluid protein(s) in spontaneous and induced ovarian cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Congenital malformations of newborn infants after clomiphene-induced ovulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Increased frequency of chromosomal anomalies in abortions after induced ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Further Clinical Experience with Clomiphene Citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Ovulation induction and congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Pregnancy after Clomiphene Citrate Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Anencephaly and ovulation stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Anencephaly and ovulation stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Letter: Ovulation stimulation and defects of neural-tube closure

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Letter: Congenital abnormalities associated with maternal clomiphene ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Outcome of pregnancy after clomiphene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

The use of pergonal for the induction of ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Spontaneous pregnancy and its outcome after human menopausal gonadotropin/human chorionic gonadotropin-induced pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Results of human menopausal gonadotropins (HMG). Therapy for anovulatory infertility using a nonvariable treatment schedule: comparison with previous reports

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

The use of human menopausal and chorionic gonadotropins for induction of ovulation. Sixteen years' experience at the Sloane Hospital for Women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Use of human menopausal gonadotropin for the induction of ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Ectopic pregnancy following treatment with human gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Menarche and puberty in daughters of amenorrheic women.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Pregnancy and the hyperprolactinemic woman

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Bromocriptine treatment of acromegaly following spontaneous conception

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

A Pregnancy in an Acromegalic Woman during Bromocriptine Treatment: Effects on Growth Hormone and Prolactin in the Maternal, Fetal, and Amniotic Compartments*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Pregnancy in hyperprolactinemic women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Successful pregnancy in an acromegalic patient during 2-Br-alpha-ergocryptine (CB-154) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Bromocriptine as prophylactic therapy in prolactinoma during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Bromocriptine, pituitary tumours, and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Delivery after bromocriptine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Pregnancy and delivery under bromocriptine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

Bromocriptine treatment during early human pregnancy: effect on the levels of prolactin, sex steroids and placental lactogen

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2949209-5

7 January 2021

10.1016/S0015-0282(16)49209-5

Identifiers

DOI

0 references

1 reference